EVH
Evolent Health, Inc.
$5.67
-0.20 (-3.41%)
At close · Jul 16
Market Cap
$637.77M
Shares
112,481,067
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.88B
-26.6%
FY2025
Net Income
-$534.51M
-767.4%
FY2025
Gross Margin
21.31%
+6.9pp
FY2025
Operating Margin
-21.86%
-20.3pp
FY2025
Diluted EPS
-$5.07
-525.9%
FY2025
Operating Cash Flow
$38.84M
+107%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.4B – $2.6B | $1.89B | $1.88B | $2.55B | $1.96B | $1.35B | $907.96M | $924.64M | $687.12M | $627.06M | $434.95M | $254.19M | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $723K | $293K | $0 | -$820K | |
| — | $1.51B | $1.48B | $2.19B | $1.5B | $1.04B | $657.55M | — | — | — | — | — | — | — | — | |
| — | $381.19M | $399.88M | $367.35M | $460.47M | $316.58M | $250.41M | — | — | — | — | — | — | — | — | |
| — | — | 21.31% | 14.38% | 23.45% | 23.42% | 27.58% | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | $15.5M | $15.1M | $19.8M | $18.2M | $17.2M | $11.1M | $5.8M | $0 | $2M | |
| — | $298.28M | $303.87M | $263.05M | $358.11M | $269.27M | $219.5M | $210.41M | $236.45M | $235.42M | $205.67M | $160.69M | $75.29M | $0 | $15.6M | |
| — | $88.1M | $89.6M | $88.1M | $91M | $35.2M | $29.4M | $32.3M | $37.1M | $27.2M | $22.8M | $12.5M | $5.8M | $0 | $400K | |
| — | $113.35M | $115.85M | $118.37M | $123.42M | $67.2M | $60.04M | $61.48M | $60.91M | $44.52M | $32.37M | $17.22M | $7.17M | $0 | $1.21M | |
| — | — | — | — | — | $0 | $7.32M | $1.28M | $0 | $0 | — | — | — | — | — | |
| — | $2.04B | — | — | — | — | $950.37M | $1.19B | $996.01M | $674.54M | $507.79M | $491.61M | $139.85M | $0 | $46.83M | |
| — | $2.31B | $2.29B | $2.6B | $2.04B | $1.35B | $950.37M | $1.19B | — | — | — | — | — | — | — | |
| — | -$419.12M | -$410.14M | -$40.49M | -$71.21M | $3.64M | -$42.41M | -$262.85M | -$308.89M | -$47.48M | -$72.84M | -$237.42M | -$42.97M | $0 | -$21.16M | |
| — | — | -21.86% | -1.58% | -3.63% | 0.27% | -4.67% | -28.43% | -44.95% | -7.57% | -16.75% | -93.4% | — | — | — | |
| — | -$305.77M | -$294.29M | $77.89M | $52.2M | $70.84M | $17.63M | -$201.37M | -$247.97M | -$2.97M | -$40.47M | -$220.2M | -$35.81M | $0 | -$19.95M | |
| — | $63.95M | $57.47M | $24.72M | $54.21M | $15.57M | $25.43M | $28.33M | $14.56M | $5.48M | $3.64M | $247K | $0 | — | — | |
| — | $3.93M | $4.19M | $5.54M | $5.26M | $1.37M | $407K | $2.63M | $3.41M | $3.44M | $1.66M | $970K | $293K | — | — | |
| — | $1.04M | $249K | $241K | -$543K | $57K | -$146K | -$118K | -$489K | $109K | $171K | $4000 | — | — | — | |
| — | $373K | $365K | -$3.44M | $1.29M | $4.57M | $13.18M | $10.04M | -$9.47M | -$4.74M | -$1.76M | -$841K | -$28.17M | -$25.25M | -$4.24M | |
| — | -$497.21M | -$534.64M | -$63.04M | -$202.41M | -$62.08M | -$29.8M | -$330.54M | -$329.99M | -$54.15M | -$76.4M | -$237.53M | $343.29M | -$25.25M | $20.03M | |
| — | -$686K | -$126K | -$1.41M | -$89.37M | -$43.38M | $483K | -$2.37M | -$22.8M | $40K | -$6.64M | -$10.76M | $23.48M | $0 | $8000 | |
| — | -$496.52M | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -$37.6M | -$334.25M | -$301.97M | -$52.66M | -$60.67M | -$159.74M | $332.49M | -$25.25M | $20.02M | |
| — | — | -28.49% | -2.41% | -5.76% | -1.42% | -4.14% | -36.15% | -43.95% | -8.4% | -13.95% | -62.84% | — | — | — | |
| — | — | — | — | — | — | $0 | $0 | -$3.61M | -$1.53M | -$9.1M | -$67.04M | -$12.68M | $0 | $0 | |
| — | -$533.78M | -$579.4M | -$93.45M | -$142.26M | -$19.16M | -$37.6M | -$334.25M | -$301.97M | -$52.66M | -$60.67M | -$159.74M | $330.31M | -$31.14M | $2.42M | |
| — | -$535.68M | -$580.27M | -$93.95M | -$142.34M | -$19.98M | -$37.69M | -$334.29M | -$302.02M | -$52.84M | -$60.67M | -$159.74M | — | — | — | |
| USD/shares | — | — | -$5.07 | -$0.81 | -$1.28 | -$0.20 | -$0.44 | -$3.94 | -$3.67 | — | -$0.94 | -$3.55 | $13.14 | -$13.46 | $2.51 |
| USD/shares | — | — | -$5.07 | -$0.81 | -$1.28 | -$0.20 | -$0.44 | -$3.94 | -$3.67 | — | -$0.94 | -$3.55 | $6.93 | -$13.46 | $0.99 |
| shares | — | — | 114.21M | 114.68M | 111.25M | 93.7M | 86.07M | 84.93M | 82.36M | 77.34M | 64.35M | 45.03M | 25.13M | 2.31M | 964K |
| shares | — | — | 114.21M | 114.68M | 111.25M | 93.7M | 86.07M | 84.93M | 82.36M | 77.34M | 64.35M | 45.03M | 46.14M | 2.31M | 2.99M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $40M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Health Information Services median 1.35×
EV/EBIT
—
Health Information Services median 26.08×
P/E (TTM)
—
Health Information Services median 34.58×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Evolent Health Services Segment | $1,876,229,000 | $2,554,741,000 | $1,963,896,000 | $1,352,013,000 | $907,957,000 | $382,360,000 | $409,531,000 | — |
| Clinical Solutions Segment | — | — | — | $944,511,000 | — | $542,279,000 | $278,217,000 | — |
| Reportable Segment | — | — | — | $1,352,013,000 | — | — | — | — |
| Services Segment | — | — | — | — | — | $924,995,000 | $687,122,000 | $547,431,000 |
| True Health Segment | — | — | — | — | — | $117,579,000 | $172,722,000 | $94,763,000 |
By Product & Service (USD)
| Component | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|
| Platforms and Operations Services | $896,753,000 | $912,649,000 | $671,919,000 | $500,190,000 | $405,484,000 |
| Transformation Services | $11,204,000 | $11,990,000 | $15,203,000 | $32,916,000 | $29,466,000 |
| Premiums Revenue | — | $117,377,000 | $171,742,000 | $93,957,000 | $0 |
| Service | — | $905,056,000 | $674,641,000 | $533,106,000 | $434,950,000 |
Key facts
CIK
1628908
CUSIP
30050B101
13F (30d)
14 filings
13 filers
Visit website
Investor relations